Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 6, 2026, 2:52 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 539551 | NSE: NH

Narayana Hrudayalaya Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 6, 2026, 2:52 am

Market Cap 36,117 Cr.
Current Price 1,767
Intrinsic Value₹1,994.46
High / Low 2,372/1,380
Stock P/E43.8
Book Value 199
Dividend Yield0.25 %
ROCE20.8 %
ROE24.2 %
Face Value 10.0
PEG Ratio2.45

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Narayana Hrudayalaya Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Narayana Hrudayalaya Ltd 36,117 Cr. 1,767 2,372/1,38043.8 1990.25 %20.8 %24.2 % 10.0
Asarfi Hospital Ltd 319 Cr. 162 221/72.919.0 45.20.00 %15.8 %14.1 % 10.0
Lotus Eye Hospital & Institute Ltd 231 Cr. 111 148/55.3355 29.20.00 %2.99 %1.22 % 10.0
Dr Lalchandani Labs Ltd 13.1 Cr. 15.1 21.2/7.2427.8 11.70.00 %2.81 %3.08 % 10.0
Industry Average12,222.33 Cr513.78111.4071.280.06%10.60%10.65%10.00

All Competitor Stocks of Narayana Hrudayalaya Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,1281,2221,2331,3051,2041,2461,3061,3671,3351,4751,5071,6442,151
Expenses 8749469639979259551,0041,0581,0271,1181,1711,2431,786
Operating Profit 254276271308279291302309307358337401365
OPM % 23%23%22%24%23%23%23%23%23%24%22%24%17%
Other Income 121515181826242318202424-29
Interest 19212123252834353741454265
Depreciation 575659556365616570828487122
Profit before tax 190214206248209225231232219254232296149
Tax % 19%19%11%9%10%15%13%14%12%22%15%13%15%
Net Profit 154173184227188191202199193197197258127
EPS in Rs 7.528.479.0011.099.209.339.859.729.449.659.6212.646.20

Last Updated: March 3, 2026, 6:16 pm

Below is a detailed analysis of the quarterly data for Narayana Hrudayalaya Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 2,151.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,644.00 Cr. (Sep 2025) to 2,151.00 Cr., marking an increase of 507.00 Cr..
  • For Expenses, as of Dec 2025, the value is 1,786.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,243.00 Cr. (Sep 2025) to 1,786.00 Cr., marking an increase of 543.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 365.00 Cr.. The value appears to be declining and may need further review. It has decreased from 401.00 Cr. (Sep 2025) to 365.00 Cr., marking a decrease of 36.00 Cr..
  • For OPM %, as of Dec 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Sep 2025) to 17.00%, marking a decrease of 7.00%.
  • For Other Income, as of Dec 2025, the value is -29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Sep 2025) to -29.00 Cr., marking a decrease of 53.00 Cr..
  • For Interest, as of Dec 2025, the value is 65.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 42.00 Cr. (Sep 2025) to 65.00 Cr., marking an increase of 23.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 122.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 87.00 Cr. (Sep 2025) to 122.00 Cr., marking an increase of 35.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 149.00 Cr.. The value appears to be declining and may need further review. It has decreased from 296.00 Cr. (Sep 2025) to 149.00 Cr., marking a decrease of 147.00 Cr..
  • For Tax %, as of Dec 2025, the value is 15.00%. The value appears to be increasing, which may not be favorable. It has increased from 13.00% (Sep 2025) to 15.00%, marking an increase of 2.00%.
  • For Net Profit, as of Dec 2025, the value is 127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 258.00 Cr. (Sep 2025) to 127.00 Cr., marking a decrease of 131.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 6.20. The value appears to be declining and may need further review. It has decreased from 12.64 (Sep 2025) to 6.20, marking a decrease of 6.44.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 4:16 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,0951,3641,6141,8782,2812,8613,1282,5833,7014,5254,8905,4836,778
Expenses 9891,2361,4341,6422,0642,5662,6942,3943,0383,5383,7224,1855,317
Operating Profit 1061281802362172954341896649871,1681,2981,461
OPM % 10%9%11%13%10%10%14%7%18%22%24%24%22%
Other Income 396-19718167212659738039
Interest 31453328558194827684112163193
Depreciation 57687680100137186184183210241278377
Profit before tax 5721511358093161-56430752888936930
Tax % 38%71%59%39%36%37%26%-75%20%19%11%16%
Net Profit 29-1921835159119-14342607790791779
EPS in Rs 974.49-0.841.044.062.512.905.82-0.7016.7329.6738.6238.6638.11
Dividend Payout % 0%0%0%0%0%35%17%0%6%8%10%12%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-165.52%210.53%295.24%-38.55%15.69%101.69%-111.76%2542.86%77.49%30.15%0.13%
Change in YoY Net Profit Growth (%)0.00%376.04%84.71%-333.79%54.24%86.01%-213.46%2654.62%-2465.37%-47.34%-30.02%

Narayana Hrudayalaya Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:15%
5 Years:12%
3 Years:14%
TTM:13%
Compounded Profit Growth
10 Years:48%
5 Years:43%
3 Years:31%
TTM:-2%
Stock Price CAGR
10 Years:%
5 Years:42%
3 Years:37%
1 Year:42%
Return on Equity
10 Years:19%
5 Years:25%
3 Years:29%
Last Year:24%

Last Updated: September 5, 2025, 11:30 am

Balance Sheet

Last Updated: December 10, 2025, 3:08 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.33200204204204204204204204204204204204
Reserves 5805686727598318779329161,2841,9272,6793,4223,855
Borrowings 3333622582178028139528267238841,6272,4282,340
Other Liabilities 2422414244686927468138339311,1551,1231,2161,342
Total Liabilities 1,1561,3711,5571,6482,5292,6402,9012,7793,1434,1705,6337,2717,742
Fixed Assets 7389131,0541,0821,8481,8382,0921,9611,9802,3362,6514,2664,399
CWIP 20201453355612206725951486135
Investments 51528796917861201322528441,0841,435
Other Assets 3463854024176377297116789641,3231,6241,8351,773
Total Assets 1,1561,3711,5571,6482,5292,6402,9012,7793,1434,1705,6337,2717,742

Below is a detailed analysis of the balance sheet data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 204.00 Cr..
  • For Reserves, as of Sep 2025, the value is 3,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,422.00 Cr. (Mar 2025) to 3,855.00 Cr., marking an increase of 433.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 2,340.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,428.00 Cr. (Mar 2025) to 2,340.00 Cr., marking a decrease of 88.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 1,342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,216.00 Cr. (Mar 2025) to 1,342.00 Cr., marking an increase of 126.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 7,742.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 4,399.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,266.00 Cr. (Mar 2025) to 4,399.00 Cr., marking an increase of 133.00 Cr..
  • For CWIP, as of Sep 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 49.00 Cr..
  • For Investments, as of Sep 2025, the value is 1,435.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,084.00 Cr. (Mar 2025) to 1,435.00 Cr., marking an increase of 351.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,835.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 62.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 7,742.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..

Notably, the Reserves (3,855.00 Cr.) exceed the Borrowings (2,340.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 110771742191822794433044851,0851,067986
Cash from Investing Activity + -168-223-150-146-520-162-189-113-267-1,176-1,458-1,325
Cash from Financing Activity + 5714018-45315-27-247-194-15988488544
Net Cash Flow -1-64228-22897-259-497205

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-227.00-234.00-78.0019.00-585.00-518.00-518.00-637.00-59.00103.000.00-1.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 453834304534313943353137
Inventory Days 645648455648353230314440
Days Payable 198146152173200177177221180224214185
Cash Conversion Cycle -90-51-70-98-100-95-111-150-108-158-138-108
Working Capital Days 2-30-12-11-10-10-22-38-16-25-30-17
ROCE %8%7%9%14%9%9%14%2%25%32%26%21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 63.85%63.85%63.85%63.85%63.85%63.85%63.85%63.85%63.85%63.85%63.85%63.27%
FIIs 10.36%11.10%11.59%11.51%10.91%10.01%9.69%9.45%9.66%10.46%10.49%11.10%
DIIs 14.14%11.95%10.89%10.23%9.51%8.22%7.90%8.68%8.52%8.09%7.76%7.91%
Government 0.00%0.00%0.00%0.00%0.01%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Public 11.01%12.45%13.05%13.78%15.12%17.29%17.94%17.39%17.34%16.98%17.29%17.09%
Others 0.63%0.63%0.62%0.62%0.62%0.62%0.62%0.62%0.62%0.62%0.62%0.62%
No. of Shareholders 75,37086,6311,02,9941,20,5061,38,0521,60,6861,78,3561,77,7921,85,7872,05,6392,26,4802,28,123

Shareholding Pattern Chart

No. of Shareholders

Narayana Hrudayalaya Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Mirae Asset Large & Midcap Fund 3,041,639 1.27 537.732,353,5942026-02-23 01:20:4729.23%
Parag Parikh Flexi Cap Fund 1,995,914 0.26 352.86N/AN/AN/A
Axis Small Cap Fund 1,663,780 1.15 294.146,641,1672025-12-08 02:06:47-74.95%
Mirae Asset Midcap Fund 1,561,483 1.56 276.051,211,4832026-02-22 06:13:5628.89%
Nippon India Small Cap Fund 944,173 0.25 166.92N/AN/AN/A
Nippon India Pharma Fund 923,911 2.07 163.341,849,5712025-12-08 02:06:47-50.05%
DSP Small Cap Fund 721,175 0.79 127.51,801,1892025-12-08 02:06:47-59.96%
Mirae Asset Multicap Fund 391,042 1.5 69.13334,7252026-02-23 00:22:0116.82%
Mirae Asset Flexi Cap Fund 251,650 1.25 44.49N/AN/AN/A
WhiteOak Capital Mid Cap Fund 219,078 0.87 38.73230,8882026-02-23 00:26:40-5.12%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 38.9038.8629.8516.85-0.70
Diluted EPS (Rs.) 38.9038.8629.8516.85-0.70
Cash EPS (Rs.) 52.3050.4939.9726.148.62
Book Value[Excl.RevalReserv]/Share (Rs.) 177.34141.18104.3572.8854.84
Book Value[Incl.RevalReserv]/Share (Rs.) 177.34141.18104.3572.8854.84
Revenue From Operations / Share (Rs.) 268.30245.56221.41181.12126.36
PBDIT / Share (Rs.) 66.9660.0750.4633.6710.29
PBIT / Share (Rs.) 53.3548.2240.1924.691.31
PBT / Share (Rs.) 45.7843.4836.7921.45-2.41
Net Profit / Share (Rs.) 38.6938.6429.6917.16-0.36
NP After MI And SOA / Share (Rs.) 38.6638.6229.6616.73-0.69
PBDIT Margin (%) 24.9524.4622.7918.598.14
PBIT Margin (%) 19.8819.6318.1413.631.03
PBT Margin (%) 17.0617.7016.6111.84-1.90
Net Profit Margin (%) 14.4115.7313.409.47-0.28
NP After MI And SOA Margin (%) 14.4115.7213.399.23-0.55
Return on Networth / Equity (%) 21.8027.3628.4422.96-1.27
Return on Capital Employeed (%) 17.9521.8225.8621.461.29
Return On Assets (%) 10.8714.0314.5610.92-0.51
Long Term Debt / Equity (X) 0.540.410.290.290.44
Total Debt / Equity (X) 0.610.500.350.360.46
Asset Turnover Ratio (%) 0.851.031.000.950.66
Current Ratio (X) 2.141.751.311.170.94
Quick Ratio (X) 2.041.651.241.090.87
Inventory Turnover Ratio (X) 49.800.000.000.000.00
Dividend Payout Ratio (NP) (%) 10.286.433.340.000.00
Dividend Payout Ratio (CP) (%) 7.604.922.480.000.00
Earning Retention Ratio (%) 89.7293.5796.660.000.00
Cash Earning Retention Ratio (%) 92.4095.0897.520.000.00
Interest Coverage Ratio (X) 9.3512.6714.8510.382.77
Interest Coverage Ratio (Post Tax) (X) 6.459.159.746.290.90
Enterprise Value (Cr.) 36133.0927191.9816202.9815629.998692.93
EV / Net Operating Revenue (X) 6.595.423.584.223.37
EV / EBITDA (X) 26.4022.1515.7122.7241.34
MarketCap / Net Operating Revenue (X) 6.305.213.504.123.21
Retention Ratios (%) 89.7193.5696.650.000.00
Price / BV (X) 9.549.077.4210.257.41
Price / Net Operating Revenue (X) 6.305.213.504.123.21
EarningsYield 0.020.030.030.020.00

After reviewing the key financial ratios for Narayana Hrudayalaya Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
  • For Cash EPS (Rs.), as of Mar 25, the value is 52.30. This value is within the healthy range. It has increased from 50.49 (Mar 24) to 52.30, marking an increase of 1.81.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.30. It has increased from 245.56 (Mar 24) to 268.30, marking an increase of 22.74.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 66.96. This value is within the healthy range. It has increased from 60.07 (Mar 24) to 66.96, marking an increase of 6.89.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 53.35. This value is within the healthy range. It has increased from 48.22 (Mar 24) to 53.35, marking an increase of 5.13.
  • For PBT / Share (Rs.), as of Mar 25, the value is 45.78. This value is within the healthy range. It has increased from 43.48 (Mar 24) to 45.78, marking an increase of 2.30.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 38.69. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 38.69, marking an increase of 0.05.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.66. This value is within the healthy range. It has increased from 38.62 (Mar 24) to 38.66, marking an increase of 0.04.
  • For PBDIT Margin (%), as of Mar 25, the value is 24.95. This value is within the healthy range. It has increased from 24.46 (Mar 24) to 24.95, marking an increase of 0.49.
  • For PBIT Margin (%), as of Mar 25, the value is 19.88. This value is within the healthy range. It has increased from 19.63 (Mar 24) to 19.88, marking an increase of 0.25.
  • For PBT Margin (%), as of Mar 25, the value is 17.06. This value is within the healthy range. It has decreased from 17.70 (Mar 24) to 17.06, marking a decrease of 0.64.
  • For Net Profit Margin (%), as of Mar 25, the value is 14.41. This value exceeds the healthy maximum of 10. It has decreased from 15.73 (Mar 24) to 14.41, marking a decrease of 1.32.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.72 (Mar 24) to 14.41, marking a decrease of 1.31.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 21.80. This value is within the healthy range. It has decreased from 27.36 (Mar 24) to 21.80, marking a decrease of 5.56.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 17.95. This value is within the healthy range. It has decreased from 21.82 (Mar 24) to 17.95, marking a decrease of 3.87.
  • For Return On Assets (%), as of Mar 25, the value is 10.87. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 10.87, marking a decrease of 3.16.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.54, marking an increase of 0.13.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.61, marking an increase of 0.11.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.03 (Mar 24) to 0.85, marking a decrease of 0.18.
  • For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 2.14, marking an increase of 0.39.
  • For Quick Ratio (X), as of Mar 25, the value is 2.04. This value exceeds the healthy maximum of 2. It has increased from 1.65 (Mar 24) to 2.04, marking an increase of 0.39.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 49.80. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 49.80, marking an increase of 49.80.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 20. It has increased from 6.43 (Mar 24) to 10.28, marking an increase of 3.85.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.60. This value is below the healthy minimum of 20. It has increased from 4.92 (Mar 24) to 7.60, marking an increase of 2.68.
  • For Earning Retention Ratio (%), as of Mar 25, the value is 89.72. This value exceeds the healthy maximum of 70. It has decreased from 93.57 (Mar 24) to 89.72, marking a decrease of 3.85.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.40. This value exceeds the healthy maximum of 70. It has decreased from 95.08 (Mar 24) to 92.40, marking a decrease of 2.68.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 9.35, marking a decrease of 3.32.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 6.45, marking a decrease of 2.70.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 36,133.09. It has increased from 27,191.98 (Mar 24) to 36,133.09, marking an increase of 8,941.11.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.59. This value exceeds the healthy maximum of 3. It has increased from 5.42 (Mar 24) to 6.59, marking an increase of 1.17.
  • For EV / EBITDA (X), as of Mar 25, the value is 26.40. This value exceeds the healthy maximum of 15. It has increased from 22.15 (Mar 24) to 26.40, marking an increase of 4.25.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
  • For Retention Ratios (%), as of Mar 25, the value is 89.71. This value exceeds the healthy maximum of 70. It has decreased from 93.56 (Mar 24) to 89.71, marking a decrease of 3.85.
  • For Price / BV (X), as of Mar 25, the value is 9.54. This value exceeds the healthy maximum of 3. It has increased from 9.07 (Mar 24) to 9.54, marking an increase of 0.47.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
  • For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Narayana Hrudayalaya Ltd as of March 6, 2026 is: ₹1,691.67

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 6, 2026, Narayana Hrudayalaya Ltd is Overvalued by 4.26% compared to the current share price ₹1,767.00

Intrinsic Value of Narayana Hrudayalaya Ltd as of March 6, 2026 is: ₹1,994.46

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 6, 2026, Narayana Hrudayalaya Ltd is Undervalued by 12.87% compared to the current share price ₹1,767.00

Last 5 Year EPS CAGR: 17.90%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -18.25, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -106.42, which is a positive sign.
  3. The company has higher reserves (1,484.77 cr) compared to borrowings (966.54 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (2.69 cr) and profit (344.46 cr) over the years.
  1. The stock has a low average ROCE of 14.67%, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narayana Hrudayalaya Ltd:
    1. Net Profit Margin: 14.41%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 17.95% (Industry Average ROCE: 10.6%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 21.8% (Industry Average ROE: 10.65%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 6.45
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.04
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 43.8 (Industry average Stock P/E: 111.4)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.61
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Narayana Hrudayalaya Ltd. is a Public Limited Listed company incorporated on 19/07/2000 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA2000PLC027497 and registration number is 027497. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 3590.12 Cr. and Equity Capital is Rs. 204.36 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesNo.258/A, Bommasandra Industrial Area, Bengaluru Karnataka 560099Contact not found
Management
NamePosition Held
Dr. Devi Prasad ShettyChairman & Wholetime Director
Mr. Viren Prasad ShettyExecutive Vice Chairman
Dr. Emmanuel RupertManaging Director & Group CEO
Dr. Kiran Mazumdar ShawNon Executive Director
Dr. Anesh ShettyNon Executive Director
Ms. Nivruti RaiIndependent Director
Ms. Terri Smith BresenhamIndependent Director
Mr. Shankar ArunachalamIndependent Director
Dr. Nachiket MorIndependent Director
Mr. Naveen TewariIndependent Director

FAQ

What is the intrinsic value of Narayana Hrudayalaya Ltd?

Narayana Hrudayalaya Ltd's intrinsic value (as of 06 March 2026) is ₹1994.46 which is 12.87% higher the current market price of ₹1,767.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹36,117 Cr. market cap, FY2025-2026 high/low of ₹2,372/1,380, reserves of ₹3,855 Cr, and liabilities of ₹7,742 Cr.

What is the Market Cap of Narayana Hrudayalaya Ltd?

The Market Cap of Narayana Hrudayalaya Ltd is 36,117 Cr..

What is the current Stock Price of Narayana Hrudayalaya Ltd as on 06 March 2026?

The current stock price of Narayana Hrudayalaya Ltd as on 06 March 2026 is ₹1,767.

What is the High / Low of Narayana Hrudayalaya Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Narayana Hrudayalaya Ltd stocks is ₹2,372/1,380.

What is the Stock P/E of Narayana Hrudayalaya Ltd?

The Stock P/E of Narayana Hrudayalaya Ltd is 43.8.

What is the Book Value of Narayana Hrudayalaya Ltd?

The Book Value of Narayana Hrudayalaya Ltd is 199.

What is the Dividend Yield of Narayana Hrudayalaya Ltd?

The Dividend Yield of Narayana Hrudayalaya Ltd is 0.25 %.

What is the ROCE of Narayana Hrudayalaya Ltd?

The ROCE of Narayana Hrudayalaya Ltd is 20.8 %.

What is the ROE of Narayana Hrudayalaya Ltd?

The ROE of Narayana Hrudayalaya Ltd is 24.2 %.

What is the Face Value of Narayana Hrudayalaya Ltd?

The Face Value of Narayana Hrudayalaya Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Narayana Hrudayalaya Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports